Corresponding with ICC data, neuronal marker MAP2 (p = 0.0008), along with NEFM (p = 0.0427) and DCX (p = 0.0367) were found to be significantly upregulated at the gene expression level. The gene discussed is MAP2; the disease is intrahepatic cholangiocarcinoma.